Structural biology of innate immunity

Annual Review of Immunology

Volumn 33, Issue , 2015, Pages 393-416

  Yin, Qian ^a,b   Fu, Tian Min ^a,b   Li, Jixi ^a,b,c   Wu, Hao ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

CGAS; Death domain superfamily; Higher order assembly; Inflammasome; RIG I like receptor; STING; Toll like receptor

Indexed keywords

AIM2 LIKE RECEPTOR; CYCLIC DINUCLEOTIDE; CYCLIC GMP AMP SYNTHASE; CYCLIC NUCLEOTIDE; DINUCLEOTIDE; DOUBLE STRANDED RNA; ENZYME; HETERODIMER; HOMODIMER; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LIGAND; MITOCHONDRIAL ANTIVIRAL SIGNALING PROTEIN; MITOCHONDRIAL PROTEIN; NLRC4 INFLAMMASOME; NUCLEIC ACID BINDING PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OLIGOMER; PROTEIN; RECEPTOR; RIG I LIKE RECEPTOR; RNA; STIMULATOR OF INTERFERON GENE PROTEIN; TOLL LIKE RECEPTOR; UBIQUITIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN BINDING;

ACTIN FILAMENT; ALLOSTERISM; ALPHA HELIX; CHEMICAL STRUCTURE; CONFORMATIONAL TRANSITION; CRYOELECTRON MICROSCOPY; CRYSTAL STRUCTURE; CYTOPLASM VESICLE; ENZYME ACTIVATION; HUMAN; INNATE IMMUNITY; LIGAND BINDING; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; MYDDOSOME; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL BIOLOGY; SUPRAMOLECULAR CHEMISTRY; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; MEMBRANE PROTEINS; PROTEIN BINDING; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84927544825     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032414-112258     Document Type: Review

References (144)

1. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-97
2. Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, et al. 1998. Genetic and physical mapping of the Lps locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24:340-55
3. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Part 1):1-13
4. O'Neill LA, Bowie AG. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-64
5. O'Neill LA. 2008. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol. Rev. 226:10-18
6. Song DH, Lee JO. 2012. Sensing of microbial molecular patterns by Toll-like receptors. Immunol. Rev. 250:216-29
7. Sims JE, Smith DE. 2010. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10:89-102
8. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, et al. 1998. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161:6871-77
9. Ferrao R,Wu H. 2012. Helical assembly in the death domain (DD) superfamily. Curr. Opin. Struct. Biol. 22:241-47
10. Napetschnig J,Wu H. 2013. Molecular basis of NF-κB signaling. Annu. Rev. Biophys. 42:443-68
11. Ferrao R, Li J, Bergamin E, Wu H. 2012. Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily. Sci. Signal. 5:re3
12. Kobe B, Kajava AV. 2001. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11:725-32
13. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, et al. 2006. The molecular structure of the TLR3 extracellular domain. J. Endotoxin Res. 12:375-78
14. Choe J, Kelker MS, Wilson IA. 2005. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309:581-85
15. Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, et al. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071-82
16. Kim HM, Park BS, Kim JI, Kim SE, Lee J, et al. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906-17
17. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, et al. 2008. Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 320:379-81
18. Park BS, Song DH, KimHM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191-95
19. Yoon SI, KurnasovO,Natarajan V, Hong M, Gudkov AV, et al. 2012. Structural basis of TLR5-flagellin recognition and signaling. Science 335:859-64
20. Tanji H, Ohto U, Shibata T, Miyake K, Shimizu T. 2013. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339:1426-29
21. Jin MS, Lee JO. 2008. Structures of TLR-ligand complexes. Curr. Opin. Immunol. 20:414-19
22. Jin MS, Lee JO. 2008. Structures of the Toll-like receptor family and its ligand complexes. Immunity 29:182-91
23. Kang JY, Lee JO. 2011. Structural biology of theToll-like receptor family. Annu. Rev. Biochem. 80:917-41
24. Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700
25. Mulero JJ, Boyle BJ, Bradley S, Bright JM, Nelken ST, et al. 2002. Three new human members of the lipid transfer/lipopolysaccharide binding protein family (LT/LBP). Immunogenetics 54:293-300
26. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. 1995. Lipopolysaccharide binding proteinmediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-88
27. Eckert JK, Kim YJ, Kim JI, Gurtler K, Oh DY, et al. 2013. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity 39:647-60
28. Kim JI, Lee CJ, Jin MS, Lee CH, Paik SG, et al. 2005. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280:11347-51
29. Erridge C, Bennett-Guerrero E, Poxton IR. 2002. Structure and function of lipopolysaccharides. Microbes Infect. 4:837-51
30. Rietschel ET, Kirikae T, Schade FU, Ulmer AJ, HolstO, et al. 1993. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187:169-90
31. Kojima S, Blair DF. 2004. The bacterial flagellar motor: structure and function of a complex molecular machine. Int. Rev. Cytol. 233:93-134
32. Hayashi F, Smith KD,Ozinsky A,HawnTR, Yi EC, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor. Nature 410:1099-103
33. Chuang TH, Ulevitch RJ. 2000. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11:372-78
34. Roach JC, Glusman G, Rowen L, Kaur A, PurcellMK, et al. 2005. The evolution of vertebrate Toll-like receptors. PNAS 102:9577-82
35. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529-31
36. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, et al. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 9. Science 303:1526-29
37. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, et al. 2008. Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science 319:624-27
38. Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, et al. 2009. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31:737-48
39. Xu Y, Tao X, Shen B, Horng T, Medzhitov R, et al. 2000. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408:111-15
40. Wang D, Zhang S,LiL,Liu X, MeiK,WangX. 2010. Structural insights into the assembly and activation of IL-1βwith its receptors. Nat. Immunol. 11:905-11
41. Thomas C, Bazan JF, Garcia KC. 2012. Structure of the activating IL-1 receptor signaling complex. Nat. Struct. Mol. Biol. 19:455-57
42. Tsutsumi N, Kimura T, Arita K, Ariyoshi M, Ohnishi H, et al. 2014 . The structural basis for receptor recognition of human interleukin-18. Nat. Commun. 5:5340
43. Liu X, Hammel M, He Y, Tainer JA, Jeng U-S, et al. 2013. Structural insights into the interaction of IL-33 with its receptors. PNAS 110:14918-23
44. NymanT, Stenmark P, Flodin S, Johansson I,Hammarstrom M, Nordlund P. 2008. The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J. Biol. Chem. 283:11861-65
45. Khan JA, Brint EK, O'Neill LA, Tong L. 2004. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J. Biol. Chem. 279:31664-70
46. Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, et al. 2009. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. PNAS 106:10260-65
47. Valkov E, Stamp A, Dimaio F, Baker D, Verstak B, et al. 2011. Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. PNAS 108:14879-84
48. Enokizono Y, Kumeta H, Funami K, Horiuchi M, Sarmiento J, et al. 2013. Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling. PNAS 110:19908-13
49. Williams SJ, Sohn KH, Wan L, Bernoux M, Sarris PF, et al. 2014. Structural basis for assembly and function of a heterodimeric plant immune receptor. Science 344:299-303
50. Wu Y, Vendome J, Shapiro L, Ben-Shaul A, Honig B. 2011. Transforming binding affinities from three dimensions to two with application to cadherin clustering. Nature 475:510-13
51. Lin SC, Lo YC,Wu H. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885-90
52. Park HH, Logette E, Rauser S, Cuenin S, Walz T, et al. 2007. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 128:533-46
53. Wang L, Yang JK, Kabaleeswaran V, Rice AJ, Cruz AC, et al. 2010. The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat. Struct. Mol. Biol. 17:1324-29
54. Ferrao R, Zhou H, Shan Y, Li Q, Shaw DE, et al. 2014. IRAK4 dimerization and transautophosphorylation are induced by Myddosome assembly. Mol. Cell 55:891-903
55. Loo YM, Gale M Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-92
56. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-5
57. Myong S, Cui S, Cornish PV, Kirchhofer A, Gack MU, et al. 2009. Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 323:1070-74
58. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF. Cell 122:669-82
59. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727-40
60. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
61. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. 2005. IPS-1, an adaptor triggering RIG-Iand Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-88
62. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, et al. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-35
63. Jiang F,RamanathanA,MillerMT, Tang GQ,GaleMJr, et al. 2011. Structural basis ofRNArecognition and activation by innate immune receptor RIG-I. Nature 479:423-27
64. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. 2011. Structural insights into RNA recognition by RIG-I. Cell 147:409-22
65. Kohlway A, Luo D, Rawling DC, Ding SC, Pyle AM. 2013. Defining the functional determinants for RNA surveillance by RIG-I. EMBO Rep. 14:772-79
66. Civril F, Bennett M, MoldtM, Deimling T,Witte G, et al. 2011. The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Rep. 12:1127-34
67. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, et al. 2008. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol. Cell 29:169-79
68. Luo D, Kohlway A, Vela A, Pyle AM. 2012. Visualizing the determinants of viral RNA recognition by innate immune sensor RIG-I. Structure 20:1983-88
69. Wu B, Peisley A, Richards C, Yao H, Zeng X, et al. 2013. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276-89
70. Wang Y, Ludwig J, Schuberth C, Goldeck M, Schlee M, et al. 2010. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol. 17:781-87
71. Lu C, Xu H, Ranjith-Kumar CT, BrooksMT, HouTY, et al. 2010. The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 18:1032-43
72. Takahasi K, Kumeta H, Tsuduki N, Narita R, Shigemoto T, et al. 2009. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 284:17465-74
73. Motz C, Schuhmann KM, Kirchhofer A, Moldt M, Witte G, et al. 2013. Paramyxovirus V proteins disrupt the fold of the RNA sensor MDA5 to inhibit antiviral signaling. Science 339:690-93
74. Peisley A, Lin C, Wu B, Orme-Johnson M, Liu M, et al. 2011. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. PNAS 108:21010-15
75. Berke IC, Modis Y. 2012. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 31:1714-26
76. Berke IC, Yu X, Modis Y, Egelman EH. 2012. MDA5 assembles into a polar helical filament on dsRNA. PNAS 109:18437-41
77. Peisley A, Wu B, Yao H, Walz T, Hur S. 2013. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 51:573-83
78. Rawling DC, Pyle AM. 2014. Parts, assembly and operation of the RIG-I family of motors. Curr. Opin. Struct. Biol. 25:25-33
79. Bruns AM, LeserGP, Lamb RA,Horvath CM. 2014. The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol. Cell 55:771-81
80. Zeng W, Sun L, Jiang X, Chen X, Hou F, et al. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-30
81. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-20
82. Peisley A, Wu B, Xu H, Chen ZJ, Hur S. 2014. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 509:110-14
83. Wu B, Peisley A, Tetrault D, Li Z, Egelman EH, et al. 2014. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol. Cell 55:511-23
84. Rathinam VA, Vanaja SK, Fitzgerald KA. 2012. Regulation of inflammasome signaling. Nat. Immunol. 13:333-42
85. Lamkanfi M, Dixit VM. 2014. Mechanisms and functions of inflammasomes. Cell 157:1013-22
86. Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323:1057-60
87. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458:509-13
88. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, et al. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458:514-18
89. Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, et al. 2009. An orthogonal proteomicgenomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10:266-72
90. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, et al. 2008. The NLR gene family: a standard nomenclature. Immunity 28:285-87
91. Vavere AL, Simon GG, George RT, Rochitte CE, Arai AE, et al. 2011. Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320 row detector computed tomography: design and implementation of the CORE320 multicenter, multinational diagnostic study. J. Cardiovasc. Comput. Tomogr. 5:370-81
92. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, et al. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596-600
93. Choubey D, Panchanathan R. 2008. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol. Lett. 119:32-41
94. Jin T, Perry A, Jiang J, Smith P, Curry JA, et al. 2012. Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36:561-71
95. YinQ, SesterDP, Tian Y, Hsiao YS, Lu A, et al. 2013. Molecular mechanism for p202-mediated specific inhibition of AIM2 inflammasome activation. Cell Rep. 4:327-39
96. Ru H, Ni X, Zhao L, CrowleyC,DingW, et al. 2013. Structural basis for termination of AIM2-mediated signaling by p202. Cell Res. 23:855-58
97. Sung MW, Watts T, Li P. 2012. Crystallographic characterization of mouse AIM2 HIN-200 domain bound to a 15 bp and an 18 bp double-stranded DNA. Acta Crystallogr. Sect. F 68:1081-84
98. Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, et al. 2002. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297:1837-48
99. Morrone SR, Wang T, Constantoulakis LM, Hooy RM, Delannoy MJ, Sohn J. 2014. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. PNAS 111:E62-71
100. Jin T, Perry A, Smith P, Jiang J, Xiao TS. 2013. Structure of the absent in melanoma 2 (AIM2) pyrin domain provides insights into the mechanisms of AIM2 autoinhibition and inflammasome assembly. J. Biol. Chem. 288:13225-35
101. Lu A, Kabaleeswaran V, Fu T, Magupalli VG,Wu H. 2014. Crystal structure of the F27G AIM2 PYD mutant and similarities of its self-association to DED/DED interactions. J. Mol. Biol. 426:1420-27
102. Hu Z, Yan C, Liu P, Huang Z,Ma R, et al. 2013. Crystal structure of NLRC4 reveals its autoinhibition mechanism. Science 341:172-75
103. Halff EF, Diebolder CA, Versteeg M, Schouten A, Brondijk TH, Huizinga EG. 2012. Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N-and C-terminal regions of flagellin. J. Biol. Chem. 287:38460-72
104. Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, et al. 2014. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156:1193-206
105. Wu J, Fernandes-Alnemri T, Alnemri ES. 2010. Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. J. Clin. Immunol. 30:693-702
106. de Alba E. 2009. Structure and interdomain dynamics of apoptosis-associated speck-like protein containing a CARD (ASC). J. Biol. Chem. 284:32932-41
107. Liepinsh E, Barbals R, Dahl E, Sharipo A, Staub E, Otting G. 2003. The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. J. Mol. Biol. 332:1155-63
108. Moriya M, Taniguchi S, Wu P, Liepinsh E, Otting G, Sagara J. 2005. Role of charged and hydrophobic residues in the oligomerization of the PYRIN domain of ASC. Biochemistry 44:575-83
109. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-78
110. Ishikawa H,Ma Z, Barber GN. 2009. STING regulates intracellular DNA-mediated, type I interferondependent innate immunity. Nature 461:788-92
111. Zhong B, Yang Y, Li S, Wang YY, Li Y, et al. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-50
112. Jin L, Waterman PM, Jonscher KR, Short CM, Reisdorph NA, Cambier JC. 2008. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28:5014-26
113. Sun W, Li Y, Chen L, Chen H, You F, et al. 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. PNAS 106:8653-58
114. Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, et al. 2011. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515-18
115. Wu J, Sun L, Chen X, Du F, Shi H, et al. 2013. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339:826-30
116. Sun L,Wu J, Du F, Chen X, Chen ZJ. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339:786-91
117. Gao P, AscanoM,Wu Y, Barchet W, Gaffney BL, et al. 2013. Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153:1094-107
118. Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, et al. 2013. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 3:1355-61
119. Ablasser A,Goldeck M, Cavlar T, Deimling T,Witte G, et al. 2013. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498:380-84
120. Kranzusch PJ, Lee AS, Berger JM, Doudna JA. 2013. Structure of human cGAS reveals a conserved family of second-messenger enzymes in innate immunity. Cell Rep. 3:1362-68
121. Civril F, Deimling T, de Oliveira Mann CC, Ablasser A,Moldt M, et al. 2013. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498:332-37
122. Kato K, Ishii R, Goto E, Ishitani R, Tokunaga F, Nureki O. 2013. Structural and functional analyses of DNA-sensing and immune activation by human cGAS. PLOS ONE 8:e76983
123. Li X, Shu C, Yi G, Chaton CT, Shelton CL, et al. 2013. Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization. Immunity 39:1019-31
124. Zhang X,Wu J, Du F, Xu H, Sun L, et al. 2014. The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep. 6:421-30
125. Donovan J, DufnerM, Korennykh A. 2013. Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase. PNAS 110:1652-57
126. Han Y, Donovan J, Rath S, Whitney G, Chitrakar A, Korennykh A. 2014. Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science 343:1244-48
127. Huang H, Zeqiraj E, Dong B, Jha BK, Duffy NM, et al. 2014. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Mol. Cell 53:221-34
128. Ouyang S, Song X, Wang Y, Ru H, ShawN, et al. 2012. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding. Immunity 36:1073-86
129. Yin Q, Tian Y, Kabaleeswaran V, Jiang X, Tu D, et al. 2012. Cyclic di-GMP sensing via the innate immune signaling protein STING. Mol. Cell 46:735-45
130. Shu C, Yi G, Watts T, Kao CC, Li P. 2012. Structure of STING bound to cyclic di-GMP reveals the mechanism of cyclic dinucleotide recognition by the immune system. Nat. Struct. Mol. Biol. 19:722-24
131. Shang G, Zhu D, Li N, Zhang J, Zhu C, et al. 2012. Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nat. Struct. Mol. Biol. 19:725-27
132. Huang YH, Liu XY, Du XX, Jiang ZF, Su XD. 2012. The structural basis for the sensing and binding of cyclic di-GMP by STING. Nat. Struct. Mol. Biol. 19:728-30
133. Zhang X, Shi H,WuJ, Zhang X, Sun L, et al. 2013. Cyclic GMP-AMP containingmixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51:226-35
134. Gao P, Ascano M, Zillinger T, Wang W, Dai P, et al. 2013. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell 154:748-62
135. Chin KH, Tu ZL, Su YC, Yu YJ, Chen HC, et al. 2013. Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING. Acta Crystallogr. D 69:352-66
136. Cavlar T, Deimling T, Ablasser A, Hopfner KP, Hornung V. 2013. Species-specific detection of the antiviral small-molecule compound CMA by STING. EMBO J. 32:1440-50
137. Kim S, Li L, Maliga Z, Yin Q, Wu H, Mitchison TJ. 2013. Anticancer flavonoids are mouse-selective STING agonists. ACS Chem. Biol. 8:1396-401
138. Paul S, Kashyap AK, Jia W, He YW, Schaefer BC. 2012. Selective autophagy of the adaptor protein Bcl10 modulates T cell receptor activation of NF-κB. Immunity 36:947-58
139. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, et al. 2008. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1βproduction. Nature 456:264-68
140. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-61
141. CaiX,Chen J,XuH,Liu S, JiangQX, et al. 2014. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 156:1207-22
142. Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, et al. 2014. TheNLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15:738-48
143. Franklin BS, Bossaller L,DeNardo D, Ratter JM, Stutz A, et al. 2014. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat. Immunol. 15:727-37
144. Wu H. 2013. Higher-order assemblies in a new paradigm of signal transduction. Cell 153:287-92